|
Page: 3D pathology of prostate biopsies with biochemical recurrence outcomes: raw H&E-analog datasets and image translation-assisted segmentation in 3D (ITAS3D) datasets (PCa_Bx_3Dpathology)
|
Jeff Tobler |
Apr 12, 2024
|
|
Page: A dataset of histopathological whole slide images for classification of Treatment effectiveness to ovarian cancer (Ovarian Bevacizumab Response)
|
Tracy Nolan |
Nov 29, 2023
|
|
Page: A DICOM dataset for evaluation of medical image de-identification (Pseudo-PHI-DICOM-Data)
|
Tracy Nolan |
Dec 01, 2023
|
|
Page: A Large-Scale CT and PET/CT Dataset for Lung Cancer Diagnosis (Lung-PET-CT-Dx)
|
Jeff Tobler |
Apr 12, 2024
|
|
Page: A morphological dataset of white blood cells from patients with four different genetic AML entities and non-malignant controls (AML-Cytomorphology_MLL_Helmholtz)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: A new 2.5 D representation for lymph node detection in CT (CT Lymph Nodes)
|
Jeff Tobler |
Apr 11, 2024
|
|
Page: A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities (Soft-tissue-Sarcoma)
|
Jeff Tobler |
Apr 15, 2024
|
|
Page: A Randomized Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (S0819)
|
Jeff Tobler |
Apr 15, 2024
|
|
Page: A Single-cell Morphological Dataset of Leukocytes from AML Patients and Non-malignant Controls (AML-Cytomorphology_LMU)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: A whole-body FDG-PET/CT dataset with manually annotated tumor lesions (FDG-PET-CT-Lesions)
|
Jeff Tobler |
Apr 12, 2024
|
|
Page: AAPM RT-MAC Grand Challenge 2019 (AAPM-RT-MAC)
|
Tracy Nolan |
Nov 29, 2023
|
|
Page: Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts (EA1141)
|
Jeff Tobler |
Apr 12, 2024
|
|
Page: Abdominal or pelvic enhanced CT images within 10 days before surgery of 230 patients with stage II colorectal cancer (StageII-Colorectal-CT)
|
Jeff Tobler |
Apr 15, 2024
|
|
Page: ACRIN 6664 (CT COLONOGRAPHY)
|
Jeff Tobler |
Apr 11, 2024
|
|
Page: ACRIN 6667 (ACRIN-Contralateral-Breast-MR)
|
Jeff Tobler |
Apr 04, 2024
|
|
Page: ACRIN 6668 (ACRIN-NSCLC-FDG-PET)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: ACRIN 6677/RTOG 0625 (ACRIN-DSC-MR-Brain)
|
Jeff Tobler |
Apr 04, 2024
|
|
Page: ACRIN 6684 (ACRIN-FMISO-Brain)
|
Jeff Tobler |
Apr 04, 2024
|
|
Page: ACRIN 6685 (ACRIN-HNSCC-FDG-PET-CT)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: ACRIN 6688 (ACRIN-FLT-Breast)
|
Jeff Tobler |
Apr 04, 2024
|
|
Page: ACRIN 6698/I-SPY2 Breast DWI (ACRIN-6698)
|
Jeff Tobler |
Apr 04, 2024
|
|
Page: Advisory Group Charter
|
Justin Kirby |
Jan 23, 2024
|
|
Page: AI-ready restained and co-registered multiplex dataset for head-and-neck carcinoma (HNSCC-mIF-mIHC-comparison)
|
Jeff Tobler |
Apr 12, 2024
|
|
Page: An Expert-Annotated Dataset of Bone Marrow Cytology in Hematologic Malignancies (Bone-Marrow-Cytomorphology_MLL_Helmholtz_Fraunhofer)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: Annotated Data for AI/ML
|
Tracy Nolan |
Nov 29, 2023
|
|
Page: Anti-PD-1 Immunotherapy Lung (Anti-PD-1_Lung)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: Anti-PD-1 Immunotherapy Melanoma (Anti-PD-1_MELANOMA)
|
Jeff Tobler |
Apr 10, 2024
|
|
Page: APOLLO Date Handling
|
Betty Levine |
Aug 19, 2021
|
|
Page: APOLLO-1-VA
|
Tracy Nolan |
May 24, 2023
|
|
Page: APOLLO-5-ESCA
|
Geri Blake |
Sep 14, 2022
|